{"name":"Standard BioTools","slug":"standard-biotools","ticker":"LAB","exchange":"NASDAQ","domain":"standardbio.com","description":"Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark","hq":"South San Francisco, CA","founded":0,"employees":"385","ceo":"","sector":"Life Sciences Tools / Proteomics","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":1.01,"stockChange":0,"stockChangePercent":0,"marketCap":"$394M","metrics":{"revenue":86255000,"revenueGrowth":4.6,"grossMargin":53.3,"rdSpend":0,"netIncome":-50082000,"cash":455176000,"dividendYield":0,"peRatio":-101,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":85331000,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":85331000},{"period":"2024-12-31","value":91008000},{"period":"2023-12-31","value":106340000},{"period":"2022-12-31","value":97948000}],"grossProfit":42543000,"grossProfitHistory":[{"period":"2025-12-31","value":42543000},{"period":"2024-12-31","value":44883000},{"period":"2023-12-31","value":50450000},{"period":"2022-12-31","value":37051000}],"rdSpend":25987000,"rdSpendHistory":[{"period":"2025-12-31","value":25987000},{"period":"2024-12-31","value":28831000},{"period":"2023-12-31","value":25948000},{"period":"2022-12-31","value":37382000}],"sgaSpend":109861000,"operatingIncome":-93305000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-93305000},{"period":"2024-12-31","value":-87006000},{"period":"2023-12-31","value":-63039000},{"period":"2022-12-31","value":-102616000}],"netIncome":-74896000,"netIncomeHistory":[{"period":"2025-12-31","value":-74896000},{"period":"2024-12-31","value":-138885000},{"period":"2023-12-31","value":-74656000},{"period":"2022-12-31","value":-190098000}],"eps":-0.2,"epsHistory":[{"period":"2025-12-31","value":-0.2},{"period":"2024-12-31","value":-0.52},{"period":"2023-12-31","value":-0.94},{"period":"2022-12-31","value":-2.43}],"cash":120863000,"cashHistory":[{"period":"2025-12-31","value":120863000},{"period":"2024-12-31","value":166728000},{"period":"2023-12-31","value":51704000},{"period":"2022-12-31","value":81309000}],"totalAssets":567754000,"totalLiabilities":143463000,"totalDebt":30827000,"equity":424291000,"operatingCashflow":-74343000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-74343000},{"period":"2024-12-31","value":-143454000},{"period":"2023-12-31","value":-43287000},{"period":"2022-12-31","value":-89370000}],"capex":-8303000,"capexHistory":[{"period":"2025-12-31","value":-8303000},{"period":"2024-12-31","value":-8355000},{"period":"2023-12-31","value":-2831000},{"period":"2022-12-31","value":-3825000}],"freeCashflow":-82646000,"dividendsPaid":null,"buybacks":0,"employees":385,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":25337000,"ebit":-22026000,"ebitda":-20735000,"period":"2025-12-31","revenue":23795000,"epsBasic":0.05,"netIncome":19283000,"rdExpense":7969000,"epsDiluted":0.05,"grossProfit":11382000,"operatingIncome":-21924000},{"sga":26595000,"ebit":-32890000,"ebitda":-31369000,"period":"2025-09-30","revenue":19552000,"epsBasic":-0.09,"netIncome":-34687000,"rdExpense":6356000,"epsDiluted":-0.09,"grossProfit":9484000,"operatingIncome":-23467000},{"sga":28105000,"ebit":-18273000,"ebitda":-14279000,"period":"2025-06-30","revenue":21762000,"epsBasic":-0.09,"netIncome":-33459000,"rdExpense":6222000,"epsDiluted":-0.09,"grossProfit":10628000,"operatingIncome":-23699000},{"sga":38707000,"ebit":-26182000,"ebitda":-22011000,"period":"2025-03-31","revenue":40795000,"epsBasic":-0.07,"netIncome":-26033000,"rdExpense":11328000,"epsDiluted":-0.07,"grossProfit":19741000,"operatingIncome":-30294000},{"sga":37588000,"ebit":-29975000,"ebitda":-26022000,"period":"2024-12-31","revenue":46718000,"epsBasic":-0.09,"netIncome":-34072000,"rdExpense":14053000,"epsDiluted":-0.09,"grossProfit":21905000,"operatingIncome":-29736000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1.01,"previousClose":1.01,"fiftyTwoWeekHigh":1.72,"fiftyTwoWeekLow":0.87,"fiftyTwoWeekRange":"0.87 - 1.72","fiftyDayAverage":0.95,"twoHundredDayAverage":1.23,"beta":1.31,"enterpriseValue":-31413200,"forwardPE":-101,"priceToBook":0.7,"priceToSales":4.57,"enterpriseToRevenue":-0.36,"enterpriseToEbitda":0.46,"pegRatio":0,"ebitda":-68210000,"ebitdaMargin":-79.1,"freeCashflow":-13438500,"operatingCashflow":-90657000,"totalDebt":29491000,"debtToEquity":5.3,"currentRatio":12.36,"returnOnAssets":-8.1,"returnOnEquity":-9.9,"analystRating":"2.0 - Buy","recommendationKey":"buy","numberOfAnalysts":2,"targetMeanPrice":1.55,"targetHighPrice":1.75,"targetLowPrice":1.35,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":1.5,"institutionHeldPercent":75.6,"sharesOutstanding":390368119,"floatShares":216771416,"sharesShort":11821128,"shortRatio":3.88,"shortPercentOfFloat":3,"epsTrailing":-0.13,"epsForward":-0.01,"revenuePerShare":0.23,"bookValue":1.44,"officers":[{"age":62,"name":"Dr. Michael  Egholm Ph.D.","title":"President, CEO & Director"},{"age":54,"name":"Mr. Hanjoon  Kim","title":"Chief Financial Officer"},{"age":43,"name":"Mr. Sean  Mackay","title":"Chief Business Officer & Senior VP"},{"age":null,"name":"Mr. Jonathan  Mickelsen","title":"VP & Chief Accounting Officer"},{"age":null,"name":"John  Graziano","title":"Vice President of Investor Relations"},{"age":51,"name":"Ms. Elizabeth R. Jensen","title":"Chief Human Resources Officer"},{"age":null,"name":"Mr. Mike  Musgnug","title":"Senior VP & Chief Commercial Officer"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.standardbio.com","phone":"650 266 6000"}}